ࡱ> MOL#` "bjbj 7BsG28L,2E-VVVVV111,,,,,,,$.hA1,11,VV,fffNVV,f,ff*+VJ П)b*,-0E-*Y28Y20+Y2+D1"Sfk111,,^111E-222  222222 Memorandum of Agreement Regarding Heart Failure Patients I. Admission Criteria for Patients with Heart Failure Presenting to the ED or Ambulatory Clinics A) All patients with ADHF who do not meet criteria for Intensive Care services should be admitted to the Internal Medicine or Family Medicine Hospitalist team on call. This includes both newly identified and previously diagnosed HF patients. B) The following patients should be admitted to the Cardiac Intensive Care Unit under the supervision of the Cardiology team (or in selected cases, the MICU team) on call, as appropriate: 1. All patients with NYHA Class III-IV HF considered to have high in-hospital mortality risk1: BUN > 43 and SBP < 115 (excluding patients with CRF on hemodialysis). 2. Suspected or diagnosed Acute Coronary Syndrome (unstable angina, acute myocardial infarction, aborted sudden cardiac death). 3. Potential life-threatening arrhythmia (sustained ventricular tachycardia, high grade a-v block, persistent symptomatic brady-or tachyarrhythmia). 4. Requiring or at risk of requiring invasive ventilatory support. 5. Cardiogenic shock or otherwise requiring chemical or mechanical circulatory support (dopamine, dobutamine, milrinone, adrenergic agonists, IAB counterpulsation, LVAD). 6. Multisystem Failure (consider MICU team admission). II. Hospitalist Service Criteria for In-patient Heart Failure Team or Cardiology Consultation A) ALL HEART FAILURE PATIENTS admitted or transferred to the Hospitalist Service require a Heart Failure Team Consultation (notify Cardiology Consult fellow). B) Additional criteria for requesting an urgent Cardiology Consultation: 1. Patients with persistent or worsening symptoms despite aggressive and sustained intervention. 2. Patients requiring CCU/ICU transfer. 3. Patients with diastolic dysfunction of unclear etiology. 4. Patients on inodilator or vasodilator infusion with worsening of heart failure. 5. Patients with suspected acute coronary syndrome (i.e. unstable angina, acute myocardial infarction, aborted sudden cardiac death, unexplained abnormal cardiac enzymes). 6. Patients with suspected significant coronary artery disease who are candidates for diagnostic angiography/percutancous or surgical coronary intervention. 7. Patients with abnormal provocative stress-test who are candidates for diagnostic angiography/percutaneous or surgical coronary intervention. 8. Patients who are being evaluated for or are post Cardiac Transplant. 9. Patients with newly identified serious arrhythmias (e.g. ventricular tachycardia, symptomatic brady or tachyarrhythmias, high grade a-v block). 10. Patients with destabilized chronic/known arrhythmias. 11. Patients with implanted mechanical devices (e.g. LVADs). 12. Patients with implanted electrical devices that require interrogation or are suspected of malfunction (e.g. pacemaker, AICD) 13. Patients who are candidates for cardiac resynchronization (i.e persistent symptoms + EF <35% + QRS interval > .12 sec). 14. All patients who are currently regularly followed by a member of the cardiology department. III. Clinical Markers for Optimal Standard of Care for Patients Admitted with Heart Failure 1. LV Function Documentation All patients with symptoms of HF MUST have documentation of LV function in the chart (by ECHO, LV angiogram, nuclear study or other appropriate means) whether done prior to (within 1 year) or during hospitalization. a) If not done previously or during this admission, clear documentation must be provided in the medical record as to why it was not done during this admission. There must also be clear documentation in the medical record that an ECHO has been scheduled as part of the patients follow-up (BEST PRACTICE: Include the ECHO appointment in the discharge instructions given to the patient). 2. ACE-I/ARB Therapy All patients with HF due to systolic dysfunction (EF<40%) MUST be on an ACE-I or ARB at the time of discharge, UNLESS contraindicated. a) If ACE-I therapy is contraindicated, there must be clear documentation in the medical record indicating that it is contraindicated, including the reason for the contraindication. b) If ARB therapy is contraindicated, there must be clear documentation in the medical record that it is contraindicated, including the reason for the contraindication EVEN IF IT IS THE SAME CONTRAINDICATION AS THAT GIVEN FOR ACE-I THERAPY. c) The specific ACE-I/ARB therapy must also be listed in the medication section of the discharge instructions (DIS) given to the patient, even if the patient was on this type of therapy at the time of admission. 3. Beta Blocker Therapy All patients with HF due to systolic dysfunction (EF<40%) should be on a long-acting B-Blocker (Carvedilol, Metoprolol XL) at the time of discharge, unless contraindicated. a) If B-Blocker is contraindicated, the reason for contraindication should be documented in the patients medical record b) If the patient is placed on a short acting B-blocker due to financial/insurance constraints, this reason must be documented. 4. Other pharmacologic interventions All medications must be listed in the medication section of the discharge instructions (DIS) given to the patient a) All patients with HF due to systolic dysfunction (EF< 40%) should be considered for low dose Aldosterone Receptor Antagonist therapy (Spironolactone, Eplerenone ) prior to discharge. b) All HF patients should be considered for aspirin and cholesterol lowering therapy as appropriate. 5. Discharge Instructions Patients written discharge instruction must include ALL of the following: (BEST PRACTICE: Use the discharge instructions (DIS)) a) Diet: Low salt and any other diet restrictions b) Self Care: Weigh your self AND Notify your doctor if you gain more than 3 pounds overnight or 5 pounds in a week c) Activity: Indicate the appropriate activity level based on all medical conditions d) Follow-up: Indicate the dates and times of follow-up appointments whenever possible, especially those made for the HF Clinic, Coumadin Clinic or for ECHO e) Medications: List all medications the patient is to take as an outpatient, include those for which a prescription is not being given. f) Symptoms: Specific instructions on what to do if symptoms occur/change/worsen. 6. Patient Education a) Patients who are active smokers or who have smoked in the last 12 months should be given written and oral education on smoking cessation prior to discharge (this must be documented in the medical record) .b) At the time of discharge, patients should be referred to the following Health Education classes: Living Well With Heart Failure Healthy Heart Diet 1 In-hospital mortality risk of ADHF is 12-22% with the defined clinical features.     4/18/07 UCI Hospitalist Program & Division of Cardiology :=abopq + B C D Y h l x  㼳wq hRCJhoVhOCJ hOCJhoVhSCJ hrCJhoVhCJ h=HCJ hYCJhoVhYCJhoVhLoCJhoVhghCJhoVh-g5CJhhgh5CJhoVh5CJhoVhgh5CJ h~N@5CJh[gh5>*CJ,9: L q  K . / $a$gd} 0^`0gdO ^`gd~N@^gd~N@ p0^p`0gd~N@^gd~N@^gdYgd-g`gdaNgd~N@$a$gd-gs""   ( 1 2 L O v p q r t     G J K L O - . / 3 T _ q r ̷ h}5CJ hY5CJ h=H5CJ h[g5CJ h5CJ h~N@5CJ hCJhoVh5eCJ h?OCJ h=HCJ hrCJ hYCJH*hoVhYCJ hYCJhoVh-gCJ hRCJhoVhghCJ3  %./03W_rwxy|?@C>?BDEklo뵯ӋhoVhUeCJhoVhghCJhoVhS&CJhoVhY#CJhoVhu0CJ h~N@CJ h&!CJ h4CJhoVhCJhoVh +CJ hCJ h~kCJ h CJ h=HCJ hOCJ h}CJhoVh=HCJ3 /0y@?lG? ^`gd~N@ p0^p`0gd~N@ ^`gd~N@`gd~N@gd-g^gd~N@oFGK>?C"#478@QT]^lm{|ĻhoVh r9CJ h xJ5CJ hO5CJ hR5CJhoVhgh5CJ haN5CJ h~N@5CJhoVh +CJ h+NCJ hgjCJhoVhu0CJhoVhS&CJhoVhY#CJ h~N@CJ hCJhoVhghCJ3m{|r H9 &L p0^p`0gdO^gdO p0^p`0gd p0^p`0gdd p0^p`0gd r9^gdCs 0^`0gd r9gd-g`gdaNgdOGWru#O  EIXY`wxz߾ߵĩߝypf]hoVhdCJh^Jh5CJhaNhghCJhaNh,'c5>*CJhaNhd5>*CJhaNhgh5>*CJhaNh5>*CJh,'chgh6CJaJhoVh r9CJ hCJ h,'cCJhoVhgjCJhoVhgh5>*CJhoVhghCJ hCsCJ hO5CJhCshCs5CJ#HKQ&-9<S_  &`o{myƽƴƁ{rhh.hR5CJhoVhRCJ hRCJ hOCJhaNhO5>*CJhO5>*CJhoVhR5>*CJhoVhO5>*CJhoVhOCJhaNhOCJhRhO5CJ hghCJ hCJhoVhgjCJhoVhCJhoVhghCJhoVh,'cCJ'f"$W"J !!`gd. p0^p`0gd. p0^p`0gdCs ^`gdCs ^`gdO^gdCs 0^`0gdh p0^p`0gdR 0^`0gdRKQfj"P[x"$&'+WY򺰪|rf]|hoVhCsCJhoVhCs5>*CJhoVhCs5CJhaNhCsCJh6CJaJhCshCs6CJaJhOhO5CJ hOCJ hCsCJhCshCs5CJhoVhghCJhR5>*CJhoVhR5>*CJhoVhRCJh.hR6CJ hR6CJ hRCJ hR5CJ$YZcvy"$%.J L M U !!!"!@!t!!!!!!!!!!ĺʟğ~ hVCJ hCJhoVhgh5>*CJhoVhCJhoVhghCJhoVhgjCJhoVh:W9CJh.h.5CJ h.CJ hRCJ hOCJhaNhCsCJ hCsCJ hCJhoVhCs5>*CJhoVhCsCJ.!!!!!!!"" "!"""r"s"t"v"w"y"z"|"}"""""ýhaNhljhlUh+Nh+NCJ hOn CJ h+NCJ h+NCJH* h}CJ hVCJ hCJhoVhghCJhoVhgh5>*CJh5>*CJ! """ "s"u"v"x"y"{"|"~""""""gd-ggdV & F gd50P:poV/ =!"#$% @@@ NormalCJ_HaJmH sH tH DAD Default Paragraph FontRiR  Table Normal4 l4a (k(No ListHH ,'c Balloon TextCJOJQJ^JaJ4@4 e^yHeader  !4 @4 e^yFooter  !B'!B aNComment ReferenceCJaJ<2< aN Comment TextCJaJ@j12@ aNComment Subject5\B9:LqK.//0y@?l G ?    m { | r  H9 &Lf"$W"J  suvxy{|~0000000000000000000000000000000000000000000000000000000000000000000000 0 0000@000@000@000@000@0@0009:LqK.//0y@?l G ?    m { | r  H9 &Lf"$W"J  s00000@0@0@00 0V008000000000000000000000000000000000000000000000000000000000000 0 000 08@`0N 0 FFFI oY!" !" "8@0(  B S  ?     8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace `!E4?OZOY< H    . ~  rssuuvvxy{|~   E zrssuuvvxy{|~3333333333Lq G f"Wqrssuuvvxy{|~rssuuvvxy{|~ Q ^Z/^%#0&3re"O0Ure\b$;| h.h)@hOJQJ^Jo(.@hOJQJ^Jo(.h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.@hOJQJ^Jo()h ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.@hOJQJ^Jo()@hOJQJ^Jo(.h@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh  ^ `OJQJo(hHh^`OJQJ^Jo(hHoh!!^!`OJQJo(hH Z/Q 0U&3\b%#"O|                            KJ46M2V On )-}d=H&!]:& +F1r5Uj6:W9 r9~N@^J xJ"L+N}P7hQRSoVTY,'c-g[gghgj~kLoe^y} c~YQ?.5eN?Oq Ou0mr(S&Y#qh.5CsUe~mOaNl>qW@xEP@Unknowng: Times New RomanTimes New Roman5Symbol?& : ArialArial5& zaTahoma?5 z Courier New;Wingdings"1hbbF 0 0!4dff 2QHP ?gh2]Admission Criteria for Patients with Heart Failure presenting to the ED or Ambulatory Clinics Administrator Administrator0         Oh+'0,8DX p|    `Admission Criteria for Patients with Heart Failure presenting to the ED or Ambulatory ClinicsAdministrator Normal.dotAdministrator2Microsoft Office Word@Ik@軃v@(@(՜.+,0H hp  *HSIS0 f ^Admission Criteria for Patients with Heart Failure presenting to the ED or Ambulatory Clinics Title  !#$%&'()*+,-./0123456789:;=>?@ABCEFGHIJKNRoot Entry F`@)P1Table"2WordDocument7BSummaryInformation(<DocumentSummaryInformation8DCompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q